Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers

Clinical Cancer Research

Volumn 8, Issue 12, 2002, Pages 3813-3819

  Offit, Kenneth ^a   Gilad, Shlomit ^b   Paglin, Shoshana ^a   Kolachana, Prema ^a   Roisman, Laila C ^b   Nafa, Khedoudja ^a   Yeugelewitz, Vincent ^a   Gonzales, Maria ^a   Robson, Mark ^a   McDermott, Deborah ^a   Pierce, Heather Hanson ^a   Kauff, Noah D ^a   Einat, Paz ^b   Jhanwar, Suresh ^a   Satagopan, Jaya M ^a   Oddoux, Carole ^c   Ellis, Nathan ^a   Skaliter, Rami ^b   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Quark Biotech Inc   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; ATM GENE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GEOGRAPHY; GERM LINE; HODGKIN DISEASE; HOMOZYGOTE; HUMAN; LYMPHOCYTE; MISSENSE MUTATION; PRIORITY JOURNAL; RADIATION; RADIATION HAZARD; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELLS, CULTURED; CHILD; COHORT STUDIES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE FREQUENCY; HODGKIN DISEASE; HUMANS; LYMPHOCYTES; MALE; MUTATION; NEOPLASMS, RADIATION-INDUCED; PROTEIN-SERINE-THREONINE KINASES; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEINS;

EID: 0036899980     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Shiloh, Y. Ataxia-telangiectasia. Close to unraveling the mystery. Eur. J. Hum. Genet., 3: 116-138, 1995.
2. Taylor, A. M. R., Metcalfe, J. A., Thick, J., and Mak, Y. F. Leukemia and lymphoma in ataxia telangiectasia. Blood, 87: 423-438, 1996.
3. Morrell, D., Cromartie, E., and Swift, M. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J. Natl. Cancer Inst. (Bethesda), 77: 89-92, 1986.
4. Pippard, E. C., Hall, A. J., Barker, D. J. P., and Bridges, B. A. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res., 48: 2929-2932, 1988.
5. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanaaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Wash. DC), 268: 1749-1753, 1995.
6. Savitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F., Shiloh, Y., and Rotman, G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4: 2025-2032, 1995.
7. Sanchez, Y., Desany, B. A., Jones, W. J., Liu, Q., Wang, B., and Elledge, S. J. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science (Wash. DC), 271: 357-360, 1996.
8. Morrow, D. M., Tagle, D. A., Shiloh, Y., Collins, F. S., and Hieter, P. TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell, 82: 831-840, 1995.
9. Greenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obermaier, B., and Petes, T. D. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human Ataxia telangiectasia gene. Cell, 82: 823-829, 1995.
10. Cortez, D., Wang, Y., Qin, J., and Elledge, S. J. Requirement of ATM-dependent phosphorylation of Brcal in the DNA damage response to double-strand breaks. Science (Wash. DC), 286: 1162-1166, 1999.
11. Harenden, D. G. The nature of ataxia telangiectasia: Problems and perspectives. Int. J. Radiat. Biol., 66: S13-S19, 1994.
12. Barlow, C., Hirotsune, S., Paylor, R., Liyange, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynshaw-Boris, A. ATM-deficient mice: A paradigm of ataxia telangiectasia. Cell, 86: 159-171, 1996.
13. Swift, M., Morrell, D., Massey, R., and Chase, C. L. Incidence of cancer in 161 families affected by Ataxia-Telangiectasia. N. Engl. J. Med., 325: 1831-1836, 1991.
14. Borreson, A. L., Anderson, T. I., Tretli, S., Heiberg, A., and Moller, P. Breast cancer and other cancers in Norwegian families with Ataxia-Telangiectasia. Genes Chromosomes Cancer, 2: 339-340, 1990.
15. Shapiro, C. L., and Mauch, P. M. Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective. J. Clin. Oncol., 10: 1662-1665, 1992.
16. Chen, J., Birkholtz, G. G., Lindblom, P., Rubio, C., and Lindblom, A. The role of ataxia telangiectasia heterozygotes in familial breast cancer. Cancer Res., 58: 1376-1379, 1998.
17. Fitzgerald, M. G., Bean, J. M., Hedge, S. R., Unsal, H., MacDonald, D. J., Harkin, D. D., Finkelstein, D. M., Isselbacher, K. J., and Haber, D. A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet., 15: 307-310, 1997.
18. Vorechovský, I., Rasio, D., Luo, L., Monaco, C., Hammarstrom, L., Webster, A. D. B., Zaloudik, J., Barbanti-Brodani, G., James, M., Russo, G., et al. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res., 56: 2726-2732, 1996.
19. Shafman, T., Levitz, S., Nixon, A. J., Gibans, L. A., Nichols, K. E., Bell, D. W., Ishioka, C., Isselbacher, K. J., Gelman, R., Garber, J., Harris, J. R., and Haber, D. A. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes Cancer, 27: 124-129, 2000.
20. Nichols, K. E., Levitz, S., Shannon, K. E., Wahrer, D. C. R., Bell, D. W., Chang, G., Hedge, S., Neuberg, D., Shafman, T., Tarbell, N. J., Mauch, P., Ishioka, C., Haber, D. A., and Diller, L. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. J. Clin. Oncol., 17: 1259-1266, 1999.
21. Broeks, A., Russell, N. S., Floore, A. N., Urbanus, J. H. M., Dahler, E. C., Van T Veer, M. B., Hagenbeek, A., Noordijik, E. M., Crommelin, M. A., van Leeuwen, F. E., and Van T Veer, L. J. Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations. Int. J. Radiat. Biol., 76: 693-698, 2000.
22. Yahalom, J., Petrek, J. A., Biddinger, P. W., Kessler, S., Dershaw, D. D., McCormick, B., Osborne, M. P., Kinne, D. A., and Rosen, P. P. Breast cancer in patients irradiated for Hodgkin's Disease: A clinical and pathologic analysis of 45 events in 37 patients. J. Clin. Oncol., 10: 1674-1681, 1992.
23. Telatar, M., Wang, Z., Udar, N., Liang, T., Bernatowska-Matusz-kiewicz, E., Lavin, M., Shiloh, Y., Concannon, P., Good, R. A., and Gatti, R. A. Ataxia-telangiectasia: Mutations in ATM cDNA detected by protein truncation screening. Am. J. Hum. Genet., 59: 40-44, 1996.
24. Clarke, R. A., Goozee, G. R., Birrell, G., Fang, Z. M., Hasnain, H., Lavin, M., and Kearsley, J. H. Absence of ATM truncations in patients with severe acute radiation reactions. Int. J. Radiat. Oncol. Biol. Phys., 41: 1021-1027, 1998.
25. Spiegelman, J. I., Mindrinos, M. N., and Oefner, P. J. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques, 29: 1084-1092, 2000.
26. Broeks, A., Urbanus, J. H. M., Floore, A. N., Dahler, E. C., Klijn, J. G. M., Rutgers, E. J. T., Devilee, P., Russell, N. S., van Leeuwen, F. E., and Van T Veer, L. J. ATM-heterozygous germline mutations contribute to breast cancer susceptibility. Am. J. Hum. Genet., 66: 494-500, 2000.
27. Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rachman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., Bliss, J. M., Stratton, M. R., and Yarnold, J. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br. J. Cancer, 78: 922-927, 1998.
28. Thorstenson, Y. R., Shen, P., Tusher, V. G., Wayne, T. L., Davis, R. W., Chu, G., and Oefner, P. J. Global analysis of ATM polymorphism reveals significant functional constraint. Am. J. Hum. Genet., 69: 396-412, 2001.
29. Dork, T., Bendix, R., Bremer, M., Rades, D., Klopper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., Weise, S., Stuhrmann, M., and Karstens, J. H. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res., 61: 7608-7615, 2001.
30. Izatt, L., Greenman, J., Hodgson, S., Ellis, D., Watts, S., Scott, G., Jacobs, C., Liebmann, R., Zvelebil, M. J., Mathew, C., and Solomon, E. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer, 26: 286-294, 2000.
31. Pecker, I., Avrahan, K. B., Gilbert, D. J., Savitsky, K., Rotman. G., Harnik, R., Fukao, T., Schrock, E., Hirotsune, S., Tagle, D. A., Collins, F. S., Wynshaw-Boris, A., Ried, T., Copeland, N. G., Jenkins, N. A., Shiloh, Y., and Ziv, Y. Identification and chromosomal localization of ATM, the mouse homologue of the ataxia-telangiectasia gene. Genomics, 35: 39-45, 1996.
32. Teraoka, S. N., Malone, K. E., Doody, D. R., Suter, N. M., Ostrander, E. A., Daling, J. R., and Concannon, P. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer (Phila.), 92: 479-487, 2001.
33. Sandoval, N., Platzer, N., Rosenthal, A., Dork, T., Bendix, R., Skawran, B., Stuhmann, M., Wegner, R. D., Sperling, K., Banin, S., Shiloh, Y., Baumer, A., Bernthaler, U., Sennefelder, H., Brohm, M., Weber, B. H., and Schindler, D. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum. Mol. Genet., 8: 69-79, 1999.
34. Stankovic, T., Kidd, A. M. J., Sutcliffe, A., McGuire, G. M., Robinson, P., Weber, P., Bedenham, T., Bradwell, A. R., Easton, D. F., Lennox, G. G., Haites, N., Byrd, P. J., and Taylor, A. M. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet., 62: 334-345, 1998.
35. Rodriguez, C., Valles, H., Causse, A., Johannsdottir, V., Eliaou, J. F., and Theillet, C. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases. Genes Chromosomes Cancer, 33: 141-149, 2002.
36. Vorechovsky, I., Luo, L., Dyer, M. J., Catovsky, D., Amlot, P. L., Yaxley, J. C., Foroni, L., Hammarstrom, L., Webster, A. D., and Yuille, M. A. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat. Genet., 17: 96-99, 1997.
37. Vanasse, G. J., Concannon, P., and Willerford, D. M. Regulated genomic instability and neoplasia in the lymphoid lineage. Blood, 94: 3997-4010, 1999.
38. Stoppa-Lyonnet, D., Lauge, A., Sigaux, F., Stern, M. H., Vanasse, G. J., Concannon, P., and Willerford, D. M. No germline ATM mutation in a series of 16 T cell prolymphocytic leukemias. Blood, 96: 374-376, 2000.
39. Maillet, P., Chappuis, P. O., Vaudan, G., Dobbie, Z., Muller, H., Hutter, P., and Sappino, A. P. A polymorphism in the ATM gene modulates the penetrance of hereditary nonpolyposis colorectal cancer. Int. J. Cancer, 88: 928-931, 2000.
40. Khanna, K. K. Cancer risks and the Atm gene: A continuing debate. J. Natl. Cancer Inst. (Bethesda), 92: 795-802, 2000.
41. Gatti, R. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations. Mol. Genet. Metab., 68: 419-423, 1999.
42. Scott, S. P., Bendix, R., Chen, P., Clark, R., Dork, T., and Lavin, M. F. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc. Natl. Acad. Sci. USA, 99: 925-930, 2002.
43. Chenevix-Trench, G., Spurdle, A. B., Gatei, M., Kelly, H., Marsh, A., Chen, X., Donn, K., Cummings, M., Nyholt, D., Jenkins, M. A., Scott, C., Pupo, G. M., Dork, T., Bendix, R., Kirk, J., Tucker, K., McCredie, M. R. E., Hopper, J. L., Sambrook, J., Mann, G. J., and Khanna, K. K. Dominant negative ATM mutations in breast cancer families. J. Natl. Cancer Inst. (Bethesda), 94: 205-215, 2002.